In this webinar, panellists from Ardigen and BioCollective took a look at microbiome analysis in Parkinson’s disease. 

If you are interested in biomarker discovery, sign-up to watch the presentation and learn more about:

• microbiome-derived biomarkers discovery
• discovery of early-onset Signature of Parkinson’s disease
• using data to stratify patients for better outcomes in clinical trials
• development of live biotherapeutic products

Get the presentation in seconds. Fill in the form opposite.